You are here

  • Home
  • Archive
  • Volume 56, Issue 10
  • SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain

Citation Tools

Article menu
Download PDFPDF
Genotype-phenotype correlations
Original article
SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lemmers RJLF, van der Stoep N, Vliet PJVD, et al
SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain
Journal of Medical Genetics 2019;56:693-700.